Amy Linsky

Amy Linsky

Auto-generated profile, based on publicly available information

Amy Linsky

General Internal Medicine, Center for Health Optimization and Implementation Research (CHOIR), and New England Geriatric Research Education and Clinical Center (GRECC), VA Boston Healthcare System, Boston, MA, USA

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 May 2010 in Archives of internal medicine (1960)
Verified
Journal Article
Open access
PDF file
ALAmy Linsky
Amy Linsky
KGKalpana Gupta
Kalpana Gupta
ELElizabeth V. Lawler
Elizabeth V. Lawler
JFJennifer R. Fonda
Jennifer R. Fonda
JHJohn A. Hermos
John A. Hermos
Proton pump inhibitors (PPIs) are among the most commonly prescribed agents in outpatient and inpatient settings, but they are often used without a clear indication.1,2 Although PPIs have been considered relatively safe, studies have demonstrated that PPI use and the use of other gastric acid suppressants are associated with a variety of infections, including Salmonella and Campylobacter gastroenteritis and community-acquired and nosocomial pneumonia.3-7

20 August 2019 in Journal of the American Geriatrics Society
Verified
Journal Article
Closed access
PDF file
ALAmy Linsky
Amy Linsky
WGWalid F. Gellad
Walid F. Gellad
JLJeffrey A. Linder
Jeffrey A. Linder
MFMark W. Friedberg
Mark W. Friedberg

1 February 2015 in Patient Education and Counseling
Verified
Journal Article
Closed access
ALAmy Linsky
Amy Linsky
SSSteven R. Simon
Steven R. Simon
BBBarbara Bokhour
Barbara Bokhour

1 May 2025 in JAMA Network Open
Verified
Journal Article
Open access
ALAmy M. Linsky
Amy M. Linsky
AMAneesa Motala
Aneesa Motala
MBMarika Booth
Marika Booth
ELEmily Lawson
Emily Lawson
PSPaul G. Shekelle
Paul G. Shekelle
Importance: Deprescribing has the potential to improve patient safety and quality of care by reducing polypharmacy and potentially inappropriate medications (PIMs), which in turn may reduce adverse drug events. Questions remain about the effectiveness of deprescribing interventions in outpatient settings.Objective: To determine the association of deprescribing interventions with reducing medication count and PIMs in community-dwelling older adults.Data Sources: Included studies were English-language human studies in PubMed and the Cochrane Library published from January 2019 to July 26, 2024, and results were supplemented with reference-mining and expert consultation.Study Selection: Studies were eligible if they were solely or primarily about deprescribing, focused on community-dwelling adults, were multisite, used a randomized trial design, and reported on the primary or secondary outcome.Data Extraction and Synthesis: Two authors extracted study design, intervention characteristics, population characteristics, and follow-up. Outcomes were extracted by the statistician and checked by a second author. Meta-analyses were conducted using random effects with the Hartung-Knapp-Sidik-Jonkman method. The study was reported following the Preferred Reporting Items for Systematic Reviews and Meta-analyses (PRISMA) criteria.Main Outcomes and Measures: The primary outcome was the number of PIMs or total medications, and the secondary outcome was proportion of persons prescribed at least 1 PIM.Results: Two authors independently screened 1586 titles from PubMed and Cochrane and 33 from other sources; 321 abstracts and 133 full-text studies were further reviewed, and disagreements were reconciled through discussion, resulting in 17 studies in 18 publications. A total of 8 studies of interventions targeting multiple medications were identified for primary outcome analysis; the random-effects pooled analysis found a mean difference of −0.14 (95% CI, −0.27 to −0.01) medications prescribed. A total of 6 studies of interventions targeting multiple medications were identified for secondary outcome analysis; the random effects pooled analysis found no significant reduction in the proportion of persons prescribed at least 1 PIM (odds ratio, 0.92 [95% CI, 0.74 to 1.14]).Conclusions and Relevance: This systematic review and meta-analysis found moderate-certainty evidence that deprescribing interventions were associated with reduced PIM and medication counts in community-dwelling older adults. While the individual-level association was very small, on an aggregated population level, the outcomes may be large, given the high prevalence of polypharmacy and PIMs in community-dwelling older adults.

25 October 2012 in BMJ Quality & Safety
Verified
Journal Article
Closed access
PDF file
ALAmy Linsky
Amy Linsky
SSSteven R Simon
Steven R Simon
Introduction Medication discrepancies are associated with adverse drug events. Electronic health records (EHRs) may reduce discrepancies, especially if integrated with pharmacy dispensing. We determined the prevalence of discrepancies within a national healthcare system with EHR–pharmacy linkage to characterise the medications involved and to identify factors associated with discrepancies. Methods We conducted a retrospective cohort study of ambulatory care patients at Veterans Affairs Boston Healthcare System, April 2010–July 2011. The primary outcome was the presence of any medication discrepancy or specific types of discrepancies: commission—present in the record but not taken by patient; omission—not present in the record; duplication—present more than once; or alteration in dose or frequency—present but taken differently than documented. Results Sixty-two patients (60%) had at least one medication discrepancy. Prevalence of commissions, omissions, duplications and alterations were 36%, 27%, 11% and 19%, respectively. The involved medications differed by type of discrepancy, but non-opioid analgesics and herbal therapies were common among commissions and omissions. In adjusted analyses, an increasing number of medications was associated with more commissions (OR 1.2; 95% CI 1.1 to 1.3) and duplications (OR 1.2; 95% CI 1.1 to 1.4) and fewer omissions (OR 0.9; 95% CI 0.8 to 1.0). Discussion In a system with a well established EHR linked to pharmacy dispensing, medication discrepancies occurred in 60% of ambulatory clinic patients. Patients with a greater number of medications were more likely to have errors of commission and duplication, but less likely to have errors of omission. Our findings highlight that relying on EHRs alone will not ensure an accurate medication list and stress the need to review medication taking thoroughly with patients to capitalise on the full potential of EHRs.

28 June 2017 in BMC Health Services Research
Verified
Journal Article
Open access
PDF file
ALAmy Linsky
Amy Linsky
MMMark Meterko
Mark Meterko
KSKelly Stolzmann
Kelly Stolzmann
SSSteven R. Simon
Steven R. Simon
One approach to prevent adverse drug events is to discontinue (“deprescribe”) medications that are outdated, not indicated, or of limited benefit relative to risk for a particular patient. However, there is little guidance to clinicians about how to integrate the process of deprescribing into the workflow of clinical practice. We sought to determine clinical prescribers’ preferences for interventions that would improve their ability to appropriately and proactively discontinue medications. We conducted a national web-based survey of 2475 prescribers [physicians, nurse practitioners (NP), physician assistants (PA), and clinical pharmacy specialists] practicing in US Veterans Affairs (VA) primary care clinics. One survey question presented 15 potential changes to medication-related practices and respondents ranked their top three choices for changes that would “most improve [their] ability to discontinue medications.” We summed the weighted rankings for each of the 15 response options. Preferences were determined for the whole sample and within subgroups of respondents defined by demographic and background characteristics, medication-relevant experience, and beliefs. Among the 326 respondents who provided rankings, the top choice for a change that would help improve their ability to discontinue medications was “Requiring all medication prescriptions to have an associated ‘indication for use.’” This preference was followed by “Assistance with follow-up of patients as they taper or discontinue medications is performed by another member of the Patient Aligned Care Team (PACT)” and “Increased patient involvement in prescribing decisions.” This combination of options, albeit in varying rank order, was the most commonly selected, with 250 respondents (77%) who answered the question including at least one of these items in their three highest ranked choices, regardless of their demographics, experience, or beliefs. Continued efforts to improve clinicians’ ability to make prescribing decisions, especially around deprescribing, have many potential benefits, including decreased pharmaceutical and health care costs, fewer adverse drug events and complications, and improved patient involvement and satisfaction with their care. Future work, whether as research or quality improvement, should incorporate clinicians’ preferences for interventions, as greater buy-in from front-line staff leads to better adoption of changes.